First Admission Length for Schizophrenia Predicts Antipsychotic Choice
(MedPage Today) -- COLORADO SPRINGS, Colo.--Using long-acting injectable (LAI) antipsychotic therapies rather than oral agents for schizophrenia was tied to demographic and clinical factors, a single-center retrospective cohort study suggested...
Read more »